News

CNW/ - Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM ...
On July 22, 2025, the Board of Directors (the “Board”) of Corporation (the “Corporation”) approved a new common stock repurchase authorization (the “New Stock Repurchase Authorization”) authorizing, ...
A second resupply trip to the Sahtu region — which some residents in the region adamantly demanded — is underway, according ...
Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsJamie DuBray - Vice President of Investor RelationsMark W.
Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.
Q2 2025 Earnings Call Transcript July 22, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.77. Operator: Ladies and gentlemen, thank you for standing ...